Compare OPTT & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTT | ECOR |
|---|---|---|
| Founded | 1984 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.4M | 81.0M |
| IPO Year | 2006 | 2018 |
| Metric | OPTT | ECOR |
|---|---|---|
| Price | $0.38 | $9.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $1.50 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 2.6M | 128.4K |
| Earning Date | 03-17-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.83 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,861,000.00 | ★ $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | $221.57 | $30.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 6.08 | ★ 27.20 |
| 52 Week Low | $0.29 | $4.16 |
| 52 Week High | $0.90 | $10.27 |
| Indicator | OPTT | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 58.65 | 77.86 |
| Support Level | $0.38 | $4.66 |
| Resistance Level | $0.40 | N/A |
| Average True Range (ATR) | 0.02 | 0.76 |
| MACD | 0.01 | 0.40 |
| Stochastic Oscillator | 71.56 | 87.31 |
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.